DK388989A - Acylcyanoguanidiner, deres fremstilling og anvendelse - Google Patents
Acylcyanoguanidiner, deres fremstilling og anvendelse Download PDFInfo
- Publication number
- DK388989A DK388989A DK388989A DK388989A DK388989A DK 388989 A DK388989 A DK 388989A DK 388989 A DK388989 A DK 388989A DK 388989 A DK388989 A DK 388989A DK 388989 A DK388989 A DK 388989A
- Authority
- DK
- Denmark
- Prior art keywords
- acylcyanoguanidines
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/42—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23020988A | 1988-08-09 | 1988-08-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK388989D0 DK388989D0 (da) | 1989-08-08 |
DK388989A true DK388989A (da) | 1990-02-10 |
Family
ID=22864326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK388989A DK388989A (da) | 1988-08-09 | 1989-08-08 | Acylcyanoguanidiner, deres fremstilling og anvendelse |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0354553A3 (da) |
JP (1) | JPH0291057A (da) |
AU (2) | AU620424B2 (da) |
DK (1) | DK388989A (da) |
HU (2) | HU9101576D0 (da) |
NZ (1) | NZ229828A (da) |
ZA (1) | ZA895200B (da) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1336963C (en) * | 1988-07-18 | 1995-09-12 | Gary James Grover | Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion |
US5643921A (en) * | 1990-09-26 | 1997-07-01 | E.R. Squibb & Sons, Inc. | Cardiopulmonary bypass and organ transplant using a potassium channel activator |
WO1992011233A1 (en) * | 1990-12-19 | 1992-07-09 | Kanebo, Ltd. | Arylcyanoguanidine derivative, production thereof, and potassium channel opening agent containing the same as active ingredient |
US5371086A (en) * | 1991-03-15 | 1994-12-06 | The Green Cross Corporation | Aminopyridine compounds |
JPH05294935A (ja) * | 1991-03-15 | 1993-11-09 | Green Cross Corp:The | アミノピリジン系化合物 |
AU4530693A (en) * | 1992-08-13 | 1994-03-15 | Upjohn Company, The | Cyanoguanidines as potassium channel blockers |
DK41193D0 (da) * | 1993-04-07 | 1993-04-07 | Neurosearch As | Ionkanalaabnere |
WO1994029280A1 (en) * | 1993-06-11 | 1994-12-22 | The Upjohn Company | Pyrimidine cyanoguanidines as k-channel blockers |
US5547966A (en) * | 1993-10-07 | 1996-08-20 | Bristol-Myers Squibb Company | Aryl urea and related compounds |
WO1995017387A1 (en) * | 1993-11-22 | 1995-06-29 | EGIS Gyógyszergyár Rt. | A novel process for preparing n''-cyano-n'-(4-pyridyl)-n-(1,2,2-trimethylpropyl)-guanidine |
AR008290A1 (es) * | 1996-08-15 | 1999-12-29 | Smithkline Beecham Corp | Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios. |
US6147098A (en) * | 1998-05-11 | 2000-11-14 | Novo Nordisk A/S | Substituted guanidines and diaminonitroethenes, their preparation and use |
DE60133743T2 (de) * | 2000-08-21 | 2009-07-02 | Pacific Corp. | Neue thiourea-derivate und pharmazeutische zusammensetzungen die diese enthalten |
DK1385823T3 (da) | 2001-04-09 | 2007-03-26 | Novartis Vaccines & Diagnostic | Guanidinoforbindelser som melanocortin-4-receptor- (MC4-R) -agonister |
US20220324809A1 (en) * | 2019-09-03 | 2022-10-13 | Salzman Group Ltd. | Atp-regulated potassium channel openers and uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2976643A (en) * | 1958-05-20 | 1961-03-28 | J W Chafer Ltd | Machine for spraying powdered materials |
GB1489879A (en) * | 1974-12-20 | 1977-10-26 | Leo Pharm Prod Ltd | N'-cyano-n'-3-pyridylguanidines |
EP0017384B1 (en) * | 1979-04-04 | 1984-02-15 | Gec-Marconi Limited | Process for bonding germanium to metal |
GB8306666D0 (en) * | 1983-03-10 | 1983-04-13 | Pfizer Ltd | Therapeutic agents |
GB8400863D0 (en) * | 1984-01-13 | 1984-02-15 | Smith Kline French Lab | Chemical compounds |
FR2579201B1 (fr) * | 1985-03-19 | 1987-05-07 | Bernard Lyon I Universite Clau | Composes chimiques perfectionnes, utilisation comme agents edulcorants et compositions contenant de tels agents |
KR870008526A (ko) * | 1986-03-13 | 1987-10-19 | 원본미기재 | 감미료 및 그 제조방법 |
US4792564A (en) * | 1986-03-14 | 1988-12-20 | The Medical College Of Wisconsin, Inc. | Method of treatment and prevention of cerebral vasospasms |
WO1988001863A1 (en) * | 1986-09-12 | 1988-03-24 | The Upjohn Company | Foams for delivery of minoxidil |
EP0301713A3 (en) * | 1987-07-07 | 1990-05-02 | Beecham Group Plc | Chroman derivatives for treatment of pulmonary hypertension |
EP0579260A1 (en) * | 1987-07-07 | 1994-01-19 | Beecham Group Plc | Use of a vasodilator for the treatment of pulmonary hypertension and/or right heart failure-related conditions |
US5011837A (en) * | 1988-08-09 | 1991-04-30 | E. R. Squibb & Sons, Inc. | Aryl cyanoguanidines: potassium channel activators and method of making same |
GB8827152D0 (en) * | 1988-11-21 | 1988-12-29 | Wellcome Found | Anti-atherosclerotic diaryl compounds |
AU623217B2 (en) * | 1989-02-03 | 1992-05-07 | Eli Lilly And Company | (-)-n"-cyano-n-3-pyridyl-n'-1,2,2-trimethyl- propylguanidine, a process for preparing the compound, and use of the compound as a medicament |
GB8908063D0 (en) * | 1989-04-11 | 1989-05-24 | Beecham Group Plc | Novel compounds |
-
1989
- 1989-07-05 NZ NZ229828A patent/NZ229828A/en unknown
- 1989-07-07 ZA ZA895200A patent/ZA895200B/xx unknown
- 1989-07-25 AU AU38959/89A patent/AU620424B2/en not_active Ceased
- 1989-08-08 HU HU911576A patent/HU9101576D0/hu not_active IP Right Cessation
- 1989-08-08 DK DK388989A patent/DK388989A/da not_active Application Discontinuation
- 1989-08-08 HU HU894067A patent/HU205070B/hu not_active IP Right Cessation
- 1989-08-09 JP JP1206582A patent/JPH0291057A/ja active Pending
- 1989-08-09 EP EP89114729A patent/EP0354553A3/en not_active Ceased
-
1991
- 1991-12-30 AU AU90075/91A patent/AU640844B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
HUT51247A (en) | 1990-04-28 |
HU205070B (en) | 1992-03-30 |
JPH0291057A (ja) | 1990-03-30 |
AU640844B2 (en) | 1993-09-02 |
ZA895200B (en) | 1990-05-30 |
DK388989D0 (da) | 1989-08-08 |
NZ229828A (en) | 1992-03-26 |
EP0354553A2 (en) | 1990-02-14 |
AU9007591A (en) | 1992-02-13 |
AU3895989A (en) | 1990-02-15 |
EP0354553A3 (en) | 1990-04-11 |
HU9101576D0 (en) | 1991-11-28 |
AU620424B2 (en) | 1992-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK374389A (da) | Arylbenzenoxazolidinoner, deres fremstilling og anvendelse | |
DK609489A (da) | Imidazolderivater, deres fremstilling og anvendelse | |
DK388989A (da) | Acylcyanoguanidiner, deres fremstilling og anvendelse | |
DK354687D0 (da) | 7-acyloxy-6-aminoacyloxypolyoxylabdaner, deres fremstilling og anvendelse | |
DK435289D0 (da) | Piperazindioner, deres fremstilling og anvendelse | |
DK193088D0 (da) | 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse | |
DK225089A (da) | 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse | |
DK8589A (da) | Pyrazol- og indazolpyridinaminer, deres fremstilling og anvendelse | |
DK469389A (da) | Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse | |
DK641989A (da) | Bis-arylphosphatestere, deres fremstilling og anvendelse | |
DK189488A (da) | Imidazothiadiazinderivater, deres fremstilling og anvendelse | |
DK196389D0 (da) | N-substituerede n-amino-pyrroler, deres fremstilling og anvendelse | |
DK223288A (da) | Benzensulfornamid-derivater, deres fremstilling og anvendelse | |
DK592389A (da) | Penemderivater, deres fremstilling og anvendelse | |
DK625287A (da) | 1-aryloxy-3-amino-2-propanoler, deres fremstilling og anvendelse | |
DK185489D0 (da) | Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse | |
DK126987D0 (da) | Pyrimidoindoler, deres fremstilling og anvendelse | |
DK455189D0 (da) | 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse | |
DK297188D0 (da) | Imidazoquinoxalinforbindelser, deres fremstilling og anvendelse | |
DK142288D0 (da) | Quinoxalinforbindelser, deres fremstilling og anvendelse | |
DK258289D0 (da) | Imidazoquinoxalin forbindelser, deres fremstilling og anvendelse | |
DK625988D0 (da) | Imidazoquinoxalinforbindelser, deres fremstilling og anvendelse | |
DK639789D0 (da) | Quinoxalinforbindelser, deres fremstilling og anvendelse | |
DK639889D0 (da) | Quinoxalinforbindelser, deres fremstilling og anvendelse | |
DK163589D0 (da) | Sakyomycin e og derivater deraf, deres fremstilling og anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |